跳至主要内容
临床试验/NCT05679648
NCT05679648尚未招募不适用

Evaluation of Hepatic Steatosis and Fibrosis in Rheumatoid Arthritis Patients: a Cross-sectional Case-control Study

Sohag University0 个研究点目标入组 100 人开始时间: 2023年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
主要终点
degree of hepatic fibrosis

研究概览

简要总结

studying the prevalence of hepatic steatosis and fibrosis in a large scale of patients with RA and healthy controls

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • RA according to the American College of Rheumatology (ACR)/EULAR 2010 criteria (Aletaha et al., 2010)
  • Age≥18 years

排除标准

  • History of hepatitis B and C virus infection.
  • Receiving hepatotoxic drugs other than RA-specific drugs.
  • Alcohol abuse (i30 g/day in men and ⩾20 g/day in women).
  • Diagnosis of Wilson's disease, α1-antitrypsin deficiency or hemochromatosis.
  • Autoimmune liver disease.
  • Pregnancy.

结局指标

主要结局

degree of hepatic fibrosis

时间窗: 1 day during examination

degree of hepatic fibrosis by FIB-4 and APRI tests

degree of hepatic steatosis

时间窗: 1 day during examination

degree of hepatic steatosis by ultrasonography and Hepatic Steatosis Index.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amr Hamed

Lecturer

Sohag University

相似试验

Hepatic Steatosis and Fibrosis in Rheumatoid... | 临床试验